Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma — Stella

View on ClinicalTrials.gov

Recruiting

Back to Seminoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

France

Gustave Roussy, Villejuif, Val de Marne

Key details

Phase

Safety & dosing

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris

Enrollment target

~271 participants

Started

June 2013

Primary completion

June 2016

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Sex

Male only

Last updated June 2016

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.